Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2023-03-17 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and explicitly states the object ('Oggetto') as 'Acquisto azioni proprie' (Purchase of own shares). It details the number of shares bought, the average price, and the total consideration for the period March 13 to March 17, 2023. This activity falls directly under the definition of a company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS). Although it is a weekly report, the core subject is the share repurchase program execution.
2023-03-17 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is an official communication from Svas Biosana S.p.A. titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase). The subject line explicitly states "Acquisto azioni proprie" (Purchase of own shares). The content details the number of shares purchased, the average price, and the total consideration during a specific weekly period (March 6 to March 10, 2023), and updates the total number of treasury shares held. This activity falls directly under the definition of a company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS). Although it is a weekly report, the specific nature of the transaction (share repurchase) makes POS more accurate than a general regulatory filing (RNS).
2023-03-10 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is an Italian 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) from Svas Biosana S.p.A. The subject ('Oggetto') explicitly states 'Acquisto azioni proprie' (Purchase of own shares). The content details the number of shares bought back during a specific weekly period (Feb 27 to Mar 3, 2023) and the total shares held post-transaction. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2023-03-03 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares the company (Svas Biosana S.p.A.) purchased during the period from February 20 to February 24, 2023, as part of an authorized share buyback program. This activity—the company transacting in its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2023-02-24 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares purchased by the company (Svas Biosana S.p.A.) during a specific period (February 13 to February 17, 2023). This activity falls directly under the definition of a company buying back or selling its own shares. This corresponds precisely to the 'Transaction in Own Shares' category (POS). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a major shareholding notification (MRQ), which deals with changes in external ownership thresholds.
2023-02-17 Italian
Fatturato consolidato 2022
Earnings Release Classification · 99% confidence The document is a press release (COMUNICATO STAMPA) announcing the preliminary consolidated turnover (Fatturato consolidato preliminare 2022) for the fiscal year 2022. It provides key financial figures (97.3 million Euro) and a breakdown by business unit, attributed to the Board of Directors' review. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, typically highlighting key figures before the full formal report (like the 10-K or IR) is issued. The document explicitly states the figures are 'preliminary' and 'not subject to audit' (non sottoposto a revisione contabile), confirming it is the initial release, not the comprehensive report itself. The document length (7511 chars) is substantial enough to contain key data, but its nature as a press release announcing results points to ER. FY 2022
2023-02-13 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.